Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Enhanced Ferroptosis Induction Susceptibility in Diffuse Large B-Cell Lymphoma through Rocaglate-Mediated Translation Inhibition

Paola Manara, Alexa Barroso, Abdessamad Youssfi Alaoui, Tyler A Cunningham, David H. Ho, Kyle Hoffman, Jonathan H. Schatz

Blood (2023) 142 (Supplement 1): 2814.

https://doi.org/10.1182/blood-2023-187443

Published: 2023

Journal Articles

The Marine Product Elatol Is a Novel Inhibitor of Mitochondrial Translation Triggering the Integrated Stress Response and Apoptosis in Leukemia and Lymphoma Cells

Tyler A. Cunningham, Priyanka Maiti, Paola Manara, Vivek Singh, Nigel Beaton, Alexey Amunts, Flavia Fontanesi, Antonio Barrientos, Jonathan H. Schatz

Blood (2022) 140 (Supplement 1): 7819.

https://doi.org/10.1182/blood-2022-166899

Published: 2022

Journal Articles

Translatome Reprogramming By Rocaglates in Lymphoma Induces Drug Resistance through up-Regulation of CD98hc, Activating Downstream AKT Survival Signaling

Paola Manara, Tyler A. Cunningham, J.J. David Ho, Caroline A. Coughlin, Jonathan H. Schatz

Blood (2022) 140 (Supplement 1): 8844.

https://doi.org/10.1182/blood-2022-166771

Published: 2022

Journal Articles

Inhibition of Mitochondrial Translation By the Marine Natural Product Elatol Shows Potent Antileukemia Activity

Priyanka Maiti, Tyler A. Cunningham, Antonio Barrientos, Jonathan H. Schatz

Blood (2021) 138 (Supplement 1): 4342.

https://doi.org/10.1182/blood-2021-153347

Published: 2021

Journal Articles

Identification of Tractable Drug-like eIF4Al Inhibitors with Potent Anti-Tumor Activity

Tyler A. Cunningham, BS, Derek Essegian, BS, MS, Stephan Schürer, PhD, Jonathan H. Schatz, MD

Blood (2019) 134 (Supplement_1): 5760.

https://doi.org/10.1182/blood-2019-130494

Published: 2019

Journal Articles

Computational Identification of Tractable Drug-like Inhibitors of eIF4A1

Derek Essegian, BS, MS, Tyler A. Cunningham, BS, Jonathan H. Schatz, MD, Stephan Schurer, PhD

Blood (2018) 132 (Supplement 1): 5802.

https://doi.org/10.1182/blood-2018-99-116829

Published: 2018

NARROW

Enhanced Ferroptosis Induction Susceptibility in Diffuse Large B-Cell Lymphoma through Rocaglate-Mediated Translation Inhibition

The Marine Product Elatol Is a Novel Inhibitor of Mitochondrial Translation Triggering the Integrated Stress Response and Apoptosis in Leukemia and Lymphoma Cells

Translatome Reprogramming By Rocaglates in Lymphoma Induces Drug Resistance through up-Regulation of CD98hc, Activating Downstream AKT Survival Signaling

Inhibition of Mitochondrial Translation By the Marine Natural Product Elatol Shows Potent Antileukemia Activity

Identification of Tractable Drug-like eIF4Al Inhibitors with Potent Anti-Tumor Activity

Computational Identification of Tractable Drug-like Inhibitors of eIF4A1

Email alerts

ASH Publications

American Society of Hematology

Enhanced Ferroptosis Induction Susceptibility in Diffuse Large B-Cell Lymphoma through Rocaglate-Mediated Translation Inhibition

The Marine Product Elatol Is a Novel Inhibitor of Mitochondrial Translation Triggering the Integrated Stress Response and Apoptosis in Leukemia and Lymphoma Cells

Translatome Reprogramming By Rocaglates in Lymphoma Induces Drug Resistance through up-Regulation of CD98hc, Activating Downstream AKT Survival Signaling

Inhibition of Mitochondrial Translation By the Marine Natural Product Elatol Shows Potent Antileukemia Activity

Identification of Tractable Drug-like eIF4Al Inhibitors with Potent Anti-Tumor Activity

Computational Identification of Tractable Drug-like Inhibitors of eIF4A1

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only